Search →

Press Releases

Date
Title
Date
09/03/24
Title
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Date
08/21/24
Title
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Date
08/06/24
Title
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results
Date
08/01/24
Title
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Date
07/22/24
Title
Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024
Date
06/03/24
Title
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Date
05/23/24
Title
Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
Date
05/23/24
Title
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
Date
05/02/24
Title
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Date
04/24/24
Title
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Overview →Stock Information →SEC Filings →Annual General Meeting →UK Annual Reports →Governance + Leadership →Presentation + Events →Analyst Coverage →Press Releases →Investor Resources →

Search